tradingkey.logo

Ekso Bionics Holdings Inc

EKSO
4.860USD
+0.040+0.83%
收盤 12/19, 16:00美東報價延遲15分鐘
12.75M總市值
虧損本益比TTM

Ekso Bionics Holdings Inc

4.860
+0.040+0.83%

關於 Ekso Bionics Holdings Inc 公司

Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves people with physical disabilities or impairments in both physical rehabilitation and mobility. It operates as one segment with two markets: Enterprise Health and Personal Health. Its products include EksoNR, which is a wearable robotic exoskeleton designed for a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower limb-powered exoskeleton; Ekso Indego Personal is a lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. It enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate, stand and walk again. Additionally, the devices assist people with a variety of upper extremity disabilities and enable industrial employees to perform challenging repetitive tasks for extended periods.

Ekso Bionics Holdings Inc簡介

公司代碼EKSO
公司名稱Ekso Bionics Holdings Inc
上市日期Apr 10, 2013
CEODavis (Scott G)
員工數量61
證券類型Ordinary Share
年結日Apr 10
公司地址101 Glacier Point
城市SAN RAFAEL
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94901
電話15109841761
網址https://eksobionics.com/
公司代碼EKSO
上市日期Apr 10, 2013
CEODavis (Scott G)

Ekso Bionics Holdings Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
19.91K
-1.34%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-6.59%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--
Mr. Scott G. Davis
Mr. Scott G. Davis
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Corinna E. Lathan
Dr. Corinna E. Lathan
Independent Director
Independent Director
--
--
Mr. Stephen Kilmer
Mr. Stephen Kilmer
Investor Relations
Investor Relations
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Steven A. Sherman
Mr. Steven A. Sherman
Executive Chairman of the Board
Executive Chairman of the Board
449.16K
+23.08%
Ms. Mary Ann Cloyd
Ms. Mary Ann Cloyd
Independent Director
Independent Director
25.23K
+166.00%
Mr. Jason C. Jones
Mr. Jason C. Jones
Chief Operating Officer
Chief Operating Officer
19.91K
-1.34%
Mr. Jerome Wong
Mr. Jerome Wong
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.56K
-6.59%
Ms. Deborah Lafer Scher
Ms. Deborah Lafer Scher
Independent Director
Independent Director
15.75K
--
Dr. Charles Li, Ph.D.
Dr. Charles Li, Ph.D.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
1.02M
49.73%
Other EMEA
613.00K
29.80%
France
365.00K
17.74%
APAC
40.00K
1.94%
Other Americas
16.00K
0.78%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月4日 週四
更新時間: 12月4日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Davis (Scott Gerald)
2.33%
Consolidated Portfolio Review Corp
1.91%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
UBS Financial Services, Inc.
0.96%
其他
92.62%
持股股東
持股股東
佔比
Davis (Scott Gerald)
2.33%
Consolidated Portfolio Review Corp
1.91%
Citadel Advisors LLC
1.14%
The Vanguard Group, Inc.
1.04%
UBS Financial Services, Inc.
0.96%
其他
92.62%
股東類型
持股股東
佔比
Individual Investor
6.59%
Investment Advisor
4.73%
Hedge Fund
1.57%
Investment Advisor/Hedge Fund
1.05%
Research Firm
0.33%
Family Office
0.03%
其他
85.70%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
64
261.39K
8.72%
--
2025Q3
67
261.39K
11.41%
+205.54K
2025Q2
64
55.85K
14.40%
-195.55K
2025Q1
62
251.40K
15.39%
-37.98K
2024Q4
61
283.25K
26.99%
-87.09K
2024Q3
58
370.34K
18.68%
+159.85K
2024Q2
61
145.58K
14.28%
+25.92K
2024Q1
67
120.72K
11.67%
-18.52K
2023Q4
71
95.15K
14.09%
+2.45K
2023Q3
71
92.88K
16.51%
-13.62K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Davis (Scott Gerald)
22.27K
0.85%
+7.04K
+46.23%
Mar 18, 2025
The Vanguard Group, Inc.
11.96K
0.46%
-27.61K
-69.77%
Jun 30, 2025
Li (Kecheng)
30.73K
1.18%
+15.75K
+105.11%
May 16, 2025
Lathan (Corinna)
25.61K
0.98%
+15.75K
+159.61%
May 16, 2025
Cloyd (Mary Ann)
25.23K
0.97%
+15.75K
+166.00%
May 16, 2025
Jones (Jason C)
14.90K
0.57%
+5.26K
+54.55%
Mar 18, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
公告日期
類型
比率
May 19, 2025
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1
Mar 24, 2020
Merger
15→1

常見問題

Ekso Bionics Holdings Inc的前五大股東是誰?

Ekso Bionics Holdings Inc的前五大股東如下:
Davis (Scott Gerald)
持有股份:22.27K
佔總股份比例:0.85%。
The Vanguard Group, Inc.
持有股份:11.96K
佔總股份比例:0.46%。
Li (Kecheng)
持有股份:30.73K
佔總股份比例:1.18%。
Lathan (Corinna)
持有股份:25.61K
佔總股份比例:0.98%。
Cloyd (Mary Ann)
持有股份:25.23K
佔總股份比例:0.97%。

Ekso Bionics Holdings Inc的前三大股東類型是什麼?

Ekso Bionics Holdings Inc 的前三大股東類型分別是:
Davis (Scott Gerald)
Consolidated Portfolio Review Corp
Citadel Advisors LLC

有多少機構持有Ekso Bionics Holdings Inc(EKSO)的股份?

截至2025Q4,共有64家機構持有Ekso Bionics Holdings Inc的股份,合計持有的股份價值約為261.39K,占公司總股份的8.72% 。與2025Q3相比,機構持股有所增加,增幅為-2.70%。

哪個業務部門對Ekso Bionics Holdings Inc的收入貢獻最大?

在FY2025Q2,--業務部門對Ekso Bionics Holdings Inc的收入貢獻最大,創收--,占總收入的--% 。
KeyAI